4.7 Article

Biosynthesis of a rosavin natural product in Escherichia coli by glycosyltransferase rational design and artificial pathway construction

Journal

METABOLIC ENGINEERING
Volume 69, Issue -, Pages 15-25

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymben.2021.10.010

Keywords

Rosavin natural product; Glycosyltransferase; Rational design; UDP-xylose; Escherichia coli

Funding

  1. National Key Research and Development Program of China [2018YFA0901900]
  2. National Natural Science Foundation of China [31770104, 31970065, U1902214]
  3. Sciences and Technology Planning Projects of Tianjin city [18YFZCSY01350, 19PTZWHZ00060]
  4. Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project [TSBICIP-KJGG-002]
  5. Youth Innovation Promotion Association of CAS [2017207, 2021175]

Ask authors/readers for more resources

This study describes a novel method for de novo production of rosavin E in Escherichia coli, achieving a titer of 92.9 mg/L and further optimizing the method to reach 782.0 mg/L. This represents an excellent example of producing a natural product with a disaccharide chain using glycosyltransferase engineering and artificial pathway construction.
Phytochemicals are rich resources for pharmaceutical and nutraceutical agents. A key challenge of accessing these precious compounds can present significant bottlenecks for development. The cinnamyl alcohol disaccharides also known as rosavins are the major bioactive ingredients of the notable medicinal plant Rhodiola rosea L. Cinnamyl-(6'-O-beta-xylopyranosyl)-O-beta-glucopyranoside (rosavin E) is a natural rosavin analogue with the arabinopyranose unit being replaced by its diastereomer xylose, which was only isolated in minute quantity from R. rosea. Herein, we described the de novo production of rosavin E in Escherichia coli. The 1,6-glucosyltransferase CaUGT3 was engineered into a xylosyltransferase converting cinnamyl alcohol monoglucoside (rosin) into rosavin E by replacing the residue T145 with valine. The enzyme activity was further elevated 2.9 times by adding the mutation N375Q. The synthesis of rosavin E from glucose was achieved with a titer of 92.9 mg/L by combining the variant CaUGT3T145V/N375Q, the UDP-xylose synthase from Sinorhizobium meliloti 1021 (SmUXS) and enzymes for rosin biosynthesis into a phenylalanine overproducing E. coli strain. The production of rosavin E was further elevated by co-overexpressing UDP-xylose synthase from Arabidopsis thaliana (AtUXS3) and SmUXS, and the titer in a 5 L bioreactor with fed-batch fermentation reached 782.0 mg/L. This work represents an excellent example of producing a natural product with a disaccharide chain by glycosyltransferase engineering and artificial pathway construction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available